Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/2010
02/16/2010CA2344435C Compositions for the treatment of male erectile dysfunction
02/16/2010CA2322641C Encapsulation of components into edible products
02/16/2010CA2287387C Methods and compositions for destruction of selected proteins
02/16/2010CA2204254C Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand
02/11/2010WO2010017329A1 Molecular entities for binding, stabilization and cellular delivery of charged molecules
02/11/2010WO2010017328A2 Cyclodextrin conjugates
02/11/2010WO2010017273A2 Tigecycline formulations
02/11/2010WO2010016611A1 Hydrogel
02/11/2010WO2010016581A1 Ultrasonic cancer therapy accelerator
02/11/2010WO2010016509A1 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid
02/11/2010WO2010016219A1 External preparation comprising fatty acid salt or benzoic acid salt of basic pharmacologically active component, and method for production thereof
02/11/2010WO2010015901A1 Hyaluronic acid-based gels including anesthetic agents
02/11/2010WO2010015900A1 Hyaluronic acid-based gels including anesthetic agents
02/11/2010WO2010015834A1 Antibodies specific for misfolded proteins and methods for their production
02/11/2010WO2010015797A1 Sertraline composition
02/11/2010WO2010015701A1 Improved bacterial polysaccharide-polypeptide conjugate compositions
02/11/2010WO2010015668A1 Conjugated proteins with prolonged in vivo efficacy
02/11/2010WO2010015556A1 Film-forming liquid formulations for drug release to hair and scalp
02/11/2010WO2010015400A2 Injectable taxane pharmaceutical composition
02/11/2010WO2010015022A1 Antigen-presenting scaffolds
02/11/2010WO2009134042A3 Arborescent oligopeptide-containing cyclotriphosphazene, preparation method thereof and drug delivery system containing the same
02/11/2010WO2009130602A3 Factor ix conjugates with extended half-lives
02/11/2010WO2009092071A3 Amino acid and peptide pro-drugs of phenolic analgesics and uses thereof
02/11/2010WO2009067605A3 Preparations, methods and kits useful for treatment of cough
02/11/2010WO2009001219A9 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
02/11/2010US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules
02/11/2010US20100036084 Biodegradable poly(beta-amino esters) and uses thereof
02/11/2010US20100036002 Pharmaceutical composition comprising porous dry matrix
02/11/2010US20100036001 Heparosan polymers and methods of making and using same for the enhancement of therapeutics
02/11/2010US20100036000 Controlled release antimicrobial compositions and methods for the treatment of otic disorders
02/11/2010US20100035999 Additives and products includings oligoesters
02/11/2010US20100035799 Method for the synthesis of anthracycline-peptide conjugates
02/11/2010US20100035757 Deodorizing super-absorbent composition
02/11/2010US20100035236 Enrichment method for variant proteins with altered binding properties
02/11/2010US20100034894 Use of Sucralose as a Granulating Agent
02/11/2010US20100034890 Combinations of formoterol and fluticasone propionate for asthma
02/11/2010US20100034888 Granulate containing a pharmaceutically active substance and method for its manufacture
02/11/2010US20100034882 Silver-containing compositions, devices and methods for making
02/11/2010US20100034868 Scaffolds for the regeneration of cartilage
02/11/2010US20100034867 Drug delivery coating for use with a medical device and methods of treating vascular injury
02/11/2010US20100034861 Dispersions of nanoureas comprising biologically active compounds
02/11/2010US20100034859 Method for making an implantable biocompatible material with mixed Pseudo-crystalline lattice and material obtainable by said method
02/11/2010US20100034838 Transdermal Administration of Active Agents for Systemic Effect
02/11/2010US20100034789 Novel carbosilane dendrimers, preparation method thereof and use of same
02/11/2010US20100034696 Ciclesonide-containing sterile aqueous suspension
02/11/2010CA2739318A1 Immunotherapeutic compositions for the treatment of alzheimer's disease
02/11/2010CA2733200A1 Conjugated proteins with prolonged in vivo efficacy
02/11/2010CA2733006A1 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
02/11/2010CA2733005A1 Truncated analogues of glucose-dependent insulinotropic polypeptide
02/11/2010CA2732973A1 Glucose-dependent insulinotropic polypeptide analogues
02/11/2010CA2732949A1 Analogues of glucose-dependent insulinotropic polypeptide
02/11/2010CA2732928A1 Hyaluronic acid-based gels including anesthetic agents
02/11/2010CA2732901A1 Injectable taxane pharmaceutical composition
02/11/2010CA2732582A1 Film-forming liquid formulations for drug release to hair and scalp
02/11/2010CA2732449A1 Fgfr extracellular domain acidic region muteins
02/11/2010CA2731791A1 Hydrogel
02/10/2010EP2151252A2 Solid film, rapidly dissolvable in liquids
02/10/2010EP2151250A1 Vitamin-Targeted imaging agents
02/10/2010EP2151247A1 Solid dialysis preparation
02/10/2010EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor
02/10/2010EP2151241A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
02/10/2010EP2150537A2 High temperature stable peptide formulation
02/10/2010EP2150278A1 Novel photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy
02/10/2010EP2150264A1 Stabilization of liquid solutions of recombinant protein for frozen storage
02/10/2010EP2150245A1 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
02/10/2010EP2150243A2 Compositions and methods for enhancing active agent absorption
02/10/2010EP2150202A1 Biodegradable peptide releasing polymers
02/10/2010EP1354896B1 Monoclonal antibody directed against the human bst2 antigen
02/10/2010CN101646464A Oligomer-opioid agonist conjugates
02/10/2010CN101646463A Bispecific fusion protein having therapeutic and diagnostic potential
02/10/2010CN101646462A Transpulmonary liposome for controlling drug arrival
02/10/2010CN101646461A Oral disintegrating tablet
02/10/2010CN101643512A Novel immunoadhesin for the prevention of rhinovirus infection
02/10/2010CN101642576A Polyethylene glycol-modified product of KGF-2 and preparation method thereof
02/10/2010CN101642575A Ointment shape medicinal substrate
02/10/2010CN101642574A Preparation method of masking agent for bitter animal medicines with irritant odor
02/10/2010CN101642573A Chitosan-based hepatic-targeted nano-particle drug delivery system and preparation method thereof
02/10/2010CN101642572A Preparation method of protective freezedrying powder of marine microorganism neuzyme
02/10/2010CN100588429C PH sensitive type anticancer pro-drug, preparation method and uses thereof
02/10/2010CN100588428C Fluorouracil-dextran and process for preparing the same
02/10/2010CN100588427C Lipophilic medicine hydroxypropyl beta cyclodextrin clathrate preparing method
02/10/2010CN100588426C Temperature sensing parents block polymer/iron oxide magnetic nano-carrier, preparation method and application thereof
02/10/2010CN100588425C Method for preparing medical use biological degradable hydrogel of containing cholic acid group
02/10/2010CN100588424C Lipid carrier and method of preparing the same
02/10/2010CN100588423C Controlled release compositions
02/10/2010CN100588396C Composition and methods for treatment of hyperplasia
02/09/2010USRE41108 Carrier or product formed of matrix having starch, sugar, fat, polyhydric alcohol and water in suitable ratios such that there exists a water activity of 0.6-0.75; for pharmaceutical, nutraceutical, or a vitamin mineral complex
02/09/2010US7659407 Pharmaceutical compounds
02/09/2010US7659389 RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
02/09/2010US7659365 Biodegradable homopolyamino acids and which can be used for the vectorization of active ingredients; cosmetic, dietetic or phytosanitaty; polylysine
02/09/2010US7659361 Maleamic acid polymer derivatives and their bioconjugates
02/09/2010US7659314 PH-sensitive polymeric micelles for drug delivery
02/09/2010US7659311 Delivery of agents such as heparin and calcitonin; greater efficacy; disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid
02/09/2010US7659254 Abuse-resistant amphetamine prodrugs
02/09/2010US7659248 a solubilizing agent, an antioxidant, and a buffer; improved storage stability and oxidation resistance
02/09/2010US7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
02/09/2010US7659061 vehicle comprising a modified and an unmodified liquid carrier with ratio of modified to unmodified of 0.00001:99.99999 to less than 0.01:99.99; one to three bioactive agents may be released on a predictable sustained basis.
02/09/2010US7658964 Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
02/09/2010US7658954 Synergistic antipyretic formulation
02/09/2010US7658952 Dialysis solutions containing pyrophosphates
1 ... 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 ... 1712